Opinion
Opinion: Price Controls Hurt Cancer Patients, Risk Future Innovation – Inside Sources
The U.S. Senate just announced legislation within Medicare Part D with the headline “lower prescription drug costs for beneficiaries living with cancer.” Behind this headline,
August 3, 2022
